Global Preventive Vaccines Market (2014-2019) - Key Vendors are Sanofi Avnetis, Merck, Glaxosmithkline, Novartis, Pfizer & Serum Institute

Jan 15, 2016, 10:43 ET from Research and Markets

DUBLIN, Jan. 15, 2016 /PRNewswire/ -- 

Research and Markets ( has announced the addition of the "Global Preventive Vaccines Market- Trends and Forecasts (2014-2019)" report to their offering.

The report estimates that close to 120 new vaccines in the pipeline of various companies across the globe set to hit the market during the forecasted period. With this in mind, the report expects the global vaccine market to grow at a CAGR of close to 12.4% until the year 2020.

There has been rapid growth in the market in recent years, with the market quadrupling in value from $5 billion in 2000 to $24 billion in 2013. Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters.

New candidates for vaccination against cancers and HIV which are under development are also projected to hit the magical milestone. Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production.

They have used significant revenues, global size, and deeper expertise to fund these R&D efforts. New technologies are also being introduced to curb the time and expense incurred for new vaccine discovery and production. But despite the success of vaccines, infectious diseases are still a major cause of illnesses worldwide and at least 40 major infectious diseases are still uncontrolled by vaccination.

Key Vendors:

  • Sanofi Avnetis
  • Merck
  • Glaxosmithkline
  • Novartis
  • Pfizer
  • Serum institute

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Global Therapeutic Proteins Market - Industry Analysis

4. Types of Vaccines

5. Vaccine market by application

6. Regional Analysis of the Vaccine market

7. Competitive Landscape

8. Key Company Profiles

For more information visit

Media Contact:

Laura Wood , +353-1-481-1716,


SOURCE Research and Markets